Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Lianpan, Dai"'
Autor:
Tongxin Zhao, Sheng Liu, Pengyan Wang, Yanfang Zhang, Xinrui Kang, Xiaoqian Pan, Linjie Li, Dedong Li, Ping Gao, Yaling An, Hao Song, Kefang Liu, Jianxun Qi, Xin Zhao, Lianpan Dai, Peipei Liu, Peiyi Wang, Guizhen Wu, Taicheng Zhu, Kun Xu, Yin Li, George F Gao
Publikováno v:
PLoS Pathogens, Vol 20, Iss 8, p e1012487 (2024)
Protective vaccines are crucial for preventing and controlling coronavirus disease 2019 (COVID-19). Updated vaccines are needed to confront the continuously evolving and circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant
Externí odkaz:
https://doaj.org/article/625043fe92fc40789c4fe5d88fbe3bec
Autor:
Chuanyu Liu, Senyu Xu, Yuxuan Zheng, Yufeng Xie, Kun Xu, Yan Chai, Tingrong Luo, Lianpan Dai, George F. Gao
Publikováno v:
Cell Reports, Vol 43, Iss 5, Pp 114235- (2024)
Summary: Nanoparticle vaccines displaying mosaic receptor-binding domains (RBDs) or spike (S) from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or other sarbecoviruses are used in preparedness against potential zoonotic outbreaks. Her
Externí odkaz:
https://doaj.org/article/f58e9356f6f14b2c918a46cde26a6879
Autor:
Mengyu Guo, Mingjing Cao, Jiufeng Sun, Ziwei Chen, Xin Wang, Lianpan Dai, George F. Gao, Yuliang Zhao, Yaling Wang, Chunying Chen
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 8, Iss 1, Pp 1-4 (2023)
Externí odkaz:
https://doaj.org/article/8a5e9b1d1ddb486faeecc3032e911052
Autor:
Shuxin Guo, Yuxuan Zheng, Zhengrong Gao, Minrun Duan, Sheng Liu, Pan Du, XiaoYu Xu, Kun Xu, Xin Zhao, Yan Chai, Peiyi Wang, Qi Zhao, George F. Gao, Lianpan Dai
Publikováno v:
Cell Discovery, Vol 9, Iss 1, Pp 1-13 (2023)
Abstract Vaccination with different vaccines has been implemented globally to counter the continuous COVID-19 pandemic. However, the vaccine-elicited antibodies have reduced efficiency against the highly mutated Omicron sub-variants. Previously, we d
Externí odkaz:
https://doaj.org/article/4441229bd67d4a40a61ca4794d6b77f9
Autor:
Yisheng Song, Jinjin Shao, Guangbiao She, Wanqiang Lv, Guoyu Chen, Jing Liu, Lili Zhang, Chengda Zhang, Jiahong Wang, Ruiyu Tian, Lianpan Dai, George F. Gao, Enqi Huang, Lijiang Zhang
Publikováno v:
npj Vaccines, Vol 8, Iss 1, Pp 1-11 (2023)
Abstract ZF2001, a protein subunit vaccine against coronavirus disease 2019 (COVID-19), contains recombinant tandem repeat of dimeric receptor-binding domain (RBD) protein of the SARS-CoV-2 spike protein with an aluminium-based adjuvant. During the d
Externí odkaz:
https://doaj.org/article/c518f251694a4f67831ee92f0c113572
Autor:
Fengqiang Cao, Sha Peng, Yaling An, Kun Xu, Tianyi Zheng, Lianpan Dai, Kenji Ogino, To Ngai, Yufei Xia, Guanghui Ma
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 8, Iss 1, Pp 1-14 (2023)
Abstract Current attempts in vaccine delivery systems concentrate on replicating the natural dissemination of live pathogens, but neglect that pathogens evolve to evade the immune system rather than to provoke it. In the case of enveloped RNA viruses
Externí odkaz:
https://doaj.org/article/1dc8087032e14c128caf4dfd831ad8a1
Autor:
Qian Chen, Pei Du, Yuxuan Han, Xuehui Ma, Rong Zhang, Xiaoyu Rong, Xu Zhao, Renyi Ma, Huiting Yang, Anqi Zheng, Qingrui Huang, Jinghua Yan, Hui Wang, Xin Zhao, Lianpan Dai, George F. Gao, Qihui Wang
Publikováno v:
Biosafety and Health, Vol 5, Iss 2, Pp 89-100 (2023)
With continuous mutations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the severe immune escape of Omicron sub-variants urges the development of next-generation broad-spectrum vaccines, especially as booster jabs after high-level
Externí odkaz:
https://doaj.org/article/abdac6603c324832b6c2a41ca0403f53
Autor:
Minrun Duan, Huixin Duan, Yaling An, Tianyi Zheng, Shengfeng Wan, Hui Wang, Xin Zhao, Lianpan Dai, Kun Xu, George F. Gao
Publikováno v:
Emerging Microbes and Infections, Vol 12, Iss 1 (2023)
ABSTRACTThe SARS-CoV-2 Omicron variants of concern (VOCs) showed severe resistance to the early-approved COVID-19 vaccines-induced immune responses. The breakthrough infections by the Omicron VOCs are currently the major challenge for pandemic contro
Externí odkaz:
https://doaj.org/article/fa5c1d44500d49c59232eee942576d36
Autor:
Yaling An, Shihua Li, Xiyue Jin, Jian-bao Han, Kun Xu, Senyu Xu, Yuxuan Han, Chuanyu Liu, Tianyi Zheng, Mei Liu, Mi Yang, Tian-Zhang Song, Baoying Huang, Li Zhao, Wen Wang, Ruhan A, Yingjie Cheng, Changwei Wu, Enqi Huang, Shilong Yang, Gary Wong, Yuhai Bi, Changwen Ke, Wenjie Tan, Jinghua Yan, Yong-Tang Zheng, Lianpan Dai, George F. Gao
Publikováno v:
Emerging Microbes and Infections, Vol 11, Iss 1, Pp 1058-1071 (2022)
Safe, efficacious, and deployable vaccines are urgently needed to control COVID-19 in the large-scale vaccination campaigns. We report here the preclinical studies of an approved protein subunit vaccine against COVID-19, ZF2001, which contains tandem
Externí odkaz:
https://doaj.org/article/ff8a374f442344f5abd669d7a990dd88
Autor:
Yanfang Zhang, Xinrui Kang, Sheng Liu, Pu Han, Wenwen Lei, Ke Xu, Zepeng Xu, Zhengrong Gao, Xuemei Zhou, Yaling An, Yuxuan Han, Kefang Liu, Xin Zhao, Lianpan Dai, Peiyi Wang, Guizhen Wu, Jianxun Qi, Kun Xu, George F Gao
Publikováno v:
PLoS Pathogens, Vol 19, Iss 9, p e1011659 (2023)
SARS-CoV-2 variants with severe immune evasion are a major challenge for COVID-19 prevention, especially the circulating Omicron XBB/BQ.1.1/BF.7 strains. Thus, the next-generation of broad-spectrum vaccines are urgently needed. Previously, we develop
Externí odkaz:
https://doaj.org/article/dee577a6f1524b6fa72c01b3e0d331b1